HealthEquity HQY Ratios & Valuation
| TTM Q1 '27 | TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70.7%+1.2pp | 69.5%+1.8pp | 67.7%+1.3pp | 66.4%+0.9pp | 65.5%+0.7pp | |
| Operating margin | 25.6%+1.0pp | 24.6%+1.8pp | 22.7%+4.3pp | 18.5%+2.1pp | 16.4%+2.9pp | |
| Net margin | 17.3%+0.9pp | 16.4%+1.5pp | 14.9%+3.4pp | 11.5%+1.7pp | 9.8%+1.7pp | |
| EBITDA margin | 37.1%+0.8pp | 36.3%+1.6pp | 34.8%+3.9pp | 30.9%+1.4pp | 29.4%+2.4pp | |
| Free cash flow margin | 36.5%+1.8pp | 34.7%+2.7pp | 32%+3.2pp | 28.8%+1.6pp | 27.2%-1.0pp | |
| Returns | ||||||
| Return on equity | 11.1%+0.9pp | 10.2%+1.2pp | 9%+2.2pp | 6.8%+1.0pp | 5.8%+1.1pp | |
| Return on assets | 6.9%+0.6pp | 6.3%+0.7pp | 5.6%+1.4pp | 4.2%+0.6pp | 3.7%+0.7pp | |
| Return on invested capital | 9.3%+0.5pp | 8.7%+0.9pp | 7.9%+1.6pp | 6.3%+0.7pp | 5.6%+0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.4×+0.2× | 3.3×-0.9× | 4.1×-0.1× | 4.2×+0.2× | 4.1×+1.0× | |
| Quick ratio | 3.4×+0.2× | 3.3×-0.9× | 4.1×-0.1× | 4.2×+0.2× | 4.1×+1.0× | |
| Cash ratio | 2×-0.1× | 2×-0.5× | 2.6×0.0× | 2.6×+0.1× | 2.5×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | 0.5×0.0× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 1.4×0.0× | 1.4×-0.2× | 1.6×-0.3× | 1.9×-0.3× | 2.2×-0.3× | |
| Interest coverage | 6.2×+0.6× | 5.6×+0.7× | 5×+1.3× | 3.7×+0.5× | 3.2×+0.5× | |
| Per Share | ||||||
| Book value per share | $24.090.0% | $24.09-1.8% | $24.54+0.3% | $24.46+1.8% | $24.02+0.9% | |
| Valuation | ||||||
| Market capitalization | $6.93B-5.3% | $7.32B-10.2% | $8.15B-2.9% | $8.39B+13.0% | $7.42B-22.4% | |
| Enterprise value | $7.65B-4.4% | $8B-9.8% | $8.87B-3.0% | $9.14B+10.9% | $8.24B-20.6% | |
| Price / earnings | 30×-4.0× | 34×-8.5× | 42.5×-15.0× | 57.5×-3.4× | 60.9×-38.0× | |
| Price / sales | 5.2×-0.4× | 5.6×-0.7× | 6.3×-0.3× | 6.6×+0.6× | 6×-2.0× | |
| Price / book | 3.4×-0.1× | 3.5×-0.3× | 3.8×-0.1× | 3.9×+0.4× | 3.5×-1.0× | |
| EV / EBITDA | 15.4×-1.4× | 16.8×-3.0× | 19.8×-3.6× | 23.3×+0.8× | 22.5×-9.4× | |
| EV / sales | 5.7×-0.4× | 6.1×-0.8× | 6.9×-0.3× | 7.2×+0.6× | 6.6×-2.0× | |
| Free cash flow yield | 7%+0.8pp | 6.2%+1.2pp | 5.1%+0.7pp | 4.4%-0.2pp | 4.5%+1.0pp | |
| Earnings yield | 3.3%+0.4pp | 2.9%+0.6pp | 2.4%+0.6pp | 1.7%+0.1pp | 1.6%+0.6pp | |
| PEG ratio | 0.3×+0.1× | 0.3×-0.2× | 0.4×-1.1× | 1.5×+0.3× | 1.2×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are HealthEquity's profit margins?
- HealthEquity (HQY) runs a 70.7% gross margin and a 25.6% operating margin, with a 17.3% net margin.
- Where do HealthEquity's ratios come from?
- Every ratio is computed from HealthEquity's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
